240 related articles for article (PubMed ID: 7690777)
1. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.
Wang RH; Phillips G; Medof ME; Mold C
J Clin Invest; 1993 Sep; 92(3):1326-35. PubMed ID: 7690777
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry.
Test ST; Mitsuyoshi J
J Lab Clin Med; 1997 Aug; 130(2):169-82. PubMed ID: 9280144
[TBL] [Abstract][Full Text] [Related]
3. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.
Schwartz RS; Tanaka Y; Fidler IJ; Chiu DT; Lubin B; Schroit AJ
J Clin Invest; 1985 Jun; 75(6):1965-72. PubMed ID: 4008648
[TBL] [Abstract][Full Text] [Related]
4. Membrane phospholipid organization in pathologic human erythrocytes.
Lubin B; Chiu D
Prog Clin Biol Res; 1982; 97():137-50. PubMed ID: 7156165
[No Abstract] [Full Text] [Related]
5. Interaction of phosphatidylserine-phosphatidylcholine liposomes with sickle erythrocytes. Evidence for altered membrane surface properties.
Schwartz RS; Düzgünes N; Chiu DT; Lubin B
J Clin Invest; 1983 Jun; 71(6):1570-80. PubMed ID: 6408122
[TBL] [Abstract][Full Text] [Related]
6. Abnormality of phospholipid transverse diffusion in sickle erythrocytes.
Zachowski A; Craescu CT; Galacteros F; Devaux PF
J Clin Invest; 1985 May; 75(5):1713-7. PubMed ID: 3998152
[TBL] [Abstract][Full Text] [Related]
7. Membrane phospholipid abnormalities in pathologic erythrocytes: a model for cell aging.
Wagner G; Chiu DT; Schwartz RS; Lubin B
Prog Clin Biol Res; 1985; 195():237-50. PubMed ID: 4059270
[No Abstract] [Full Text] [Related]
8. Complement activation in sickle cell disease: a liposome model.
Tomasko MA; Chudwin DS
J Lab Clin Med; 1988 Aug; 112(2):248-53. PubMed ID: 2969403
[TBL] [Abstract][Full Text] [Related]
9. Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies.
Liu SC; Yi SJ; Mehta JR; Nichols PE; Ballas SK; Yacono PW; Golan DE; Palek J
J Clin Invest; 1996 Jan; 97(1):29-36. PubMed ID: 8550846
[TBL] [Abstract][Full Text] [Related]
10. Effect of membrane phospholipids on activation of the alternative complement pathway.
Mold C
J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
[TBL] [Abstract][Full Text] [Related]
11. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
12. Abnormal membrane phospholipid asymmetry in sickle erythrocytes and its pathophysiologic significance.
Lubin B; Chiu D; Roelofsen B; Van Deenen LL
Prog Clin Biol Res; 1981; 56():171-93. PubMed ID: 7330009
[No Abstract] [Full Text] [Related]
13. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Kean LS; Brown LE; Nichols JW; Mohandas N; Archer DR; Hsu LL
Exp Hematol; 2002 May; 30(5):394-402. PubMed ID: 12031645
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the contents of membrane phospholipid and membrane phospholipid asymmetry in glucose-6-phosphate dehydrogenase deficient erythrocyte].
Zou C; Tian X; Yan H
Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):192-4. PubMed ID: 11243134
[TBL] [Abstract][Full Text] [Related]
16. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
Mold C; Walter EI; Medof ME
J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
[TBL] [Abstract][Full Text] [Related]
17. In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats.
Jain SK
J Clin Invest; 1985 Jul; 76(1):281-6. PubMed ID: 4019780
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
19. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
20. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations.
Wood BL; Gibson DF; Tait JF
Blood; 1996 Sep; 88(5):1873-80. PubMed ID: 8781447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
